Back
Mattel, Inc. 10K Form
Sell
37
MAT
Mattel, Inc.
Last Price:
$15.82
Seasonality Move:
4.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-30 | 10Q | MAT/Mattel, Inc. Quarterly |
| 2024-03-15 | 10K | MAT/Mattel, Inc. Annual |
| 2023-11-09 | 10Q | MAT/Mattel, Inc. Quarterly |
| 2023-08-01 | 10Q | MAT/Mattel, Inc. Quarterly |
| 2023-05-02 | 10Q | MAT/Mattel, Inc. Quarterly |
| 2023-02-22 | 10K | MAT/Mattel, Inc. Annual |
Receive MAT News And Ratings
See the #1 stock for the next 7 days that we like better than MAT
MAT Financial Statistics
Sales & Book Value
| Annual Sales: | $5.3B |
|---|---|
| Cash Flow: | $739.4M |
| Price / Cash Flow: | 12.57 |
| Annual Sales: | $7.41 |
| Price / Book: | 2.18 |
Profitability
| EPS (TTM): | 1.25890 |
|---|---|
| Net Income (TTM): | $397.7M |
| Gross Margin: | $2.6B |
| Return on Equity: | 17.98% |
| Return on Assets: | 6.17% |
Mattel, Inc. Earnings Forecast
Key Mattel, Inc. Financial Ratios
-
The Gross Profit Margin over the past 45 years for MAT is 48.62%.
-
The Selling, General & Administrative Expenses for MAT have been equal to 38.51% of Gross Profit Margin.
-
The Research & Development expenses have been 4.25% of Revenue.
-
The Interest Expense is 29.85% of Operating Income.
-
The Net Earning history of MAT is 7.43% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 29 years.
Mattel, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Leisure Products |
| Sector: | Consumer Discretionary |
| Current Symbol: | MAT |
| CUSIP: | 577081 |
| Website: | corporate.mattel.com |
Debt
| Debt-to-Equity Ratio: | 1.2 |
|---|---|
| Current Ratio: | 2.15 |
| Quick Ratio: | 1.62 |
Price-to-Earnings
| Trailing P/E Ratio: | 13.06 |
|---|---|
| Forward P/E Ratio: | 10.47 |
MAT Technical Analysis vs Fundamental Analysis
Sell
37
Mattel, Inc. (MAT)
is a Sell
Is Mattel, Inc. a Buy or a Sell?
-
Mattel, Inc. stock is rated a SellThe current Mattel, Inc. [MAT] share price is $15.84. The Score for MAT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.